News | December 04, 2014

More than 500 prostate biopsies have been performed utilizing this technology

biopsy systems, prostate, 3-d technology

December 4, 2014 — Chesapeake Urology Associates offers a state-of-the-art prostate cancer diagnostic, which fuses detailed MRI scans with live, real-time ultrasound images of the prostate. This biopsy system provides Chesapeake urologists with the capability to pinpoint tumors within the prostate gland, leading to more targeted treatment planning and better outcomes.

By combining advanced MRI imaging with 3-D ultrasound technology, this new biopsy system:

  • Creates a 3-D map of the prostate
  • Identifies suspicious lesions or targets on MRI
  • Fuses or overlaps the 3-D MRI image onto the real-time 3-D ultrasound image of the prostate
  • Provides clear visualization of the biopsy needle and the targeted lesion for accurate guidance
  • Stores the exact location of each biopsy sample for future referencebopsy

 

Unlike the standard 2-D TRUS-guided prostate biopsy, which takes random tissue samples from the prostate and has a higher rate of missing cancerous cells within the gland, the 3-D Ultrasound/MRI Fusion Biopsy combines the clarity of an MRI image with a 3-D ultrasound image. This creates an enhanced 3-D map of the prostate for improved visualization of the gland, allowing determination of the exact location of potential tumors.

For more information: www.chesapeakeurology.com


Additional Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Oct. 8, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., has announced new findings published in ...

Time October 13, 2026
arrow
News | Digital Pathology

Sept. 24, 2026 — Leica Biosystems,has added two Paige digital pathology AI-enabled products from Tempus to its Aperio AI ...

Time September 25, 2026
arrow
News | Molecular Imaging

Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...

Time September 23, 2026
arrow
News | Radiation Oncology

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...

Time July 10, 2026
arrow
Subscribe Now